 21172891|identification|C0020792^C0205396|start=0|end=14|PHYS^CONC
 21172891|acute myeloblastic leukemia|C0023467|start=32|end=59|DISO
 21172891|benefit|C0814225|start=64|end=71|CONC
 21172891|addition|C0332287^C1883712|start=81|end=89|CONC
 21172891|mrc|C1540289^C2698590|start=131|end=134|GENE
 21172891|trial|C0008976|start=141|end=146|PROC
 21172891|purpose|C1285529|start=148|end=155|CONC
 21172891|antibody|C1621287^C3665580|start=157|end=165|PHYS^ANAT
 21172891|chemotherapy|C0392920^C3665472^C0013217|start=175|end=187|PROC^CONC
 21172891|acute myeloid leukemia|C2984331^C0023467^C3541370|start=192|end=214|DISO^CONC
 21172891|aml|C0023467|start=216|end=219|DISO
 21172891|may|C3812381|start=221|end=224|CONC
 21172891|permit|C0023636|start=225|end=231|CONC
 21172891|treatment|C1705169^C0039798^C1533734^C3161471^C1522326^C3538994^C0087111|start=237|end=246|PROC^CONC
 21172891|administered|C1521801|start=253|end=265|CONC
 21172891|toxicity|C0600688^C0040539|start=285|end=293|DISO^CONC
 21172891|cd33|C1439292^C3815866|start=352|end=356|PROC^GENE
 21172891|binding|C1145667^C1167622^C0243122|start=401|end=408|PHYS^ACTI^CONC
 21172891|established|C1272684^C0443211|start=439|end=450|CONC
 21172891|combine|C0336789|start=474|end=481|OBJC
 21172891|conventional|C0439858|start=490|end=502|CONC
 21172891|chemotherapy|C0392920^C3665472^C0013217|start=503|end=515|PROC^CONC
 21172891|report|C0684224^C3273238^C0700287|start=524|end=530|PROC^CONC
 21172891|large|C0549177^C1416798|start=533|end=538|GENE^CONC
 21172891|randomized|C3815594^C0034656|start=539|end=549|PROC
 21172891|trial|C0008976|start=550|end=555|PROC
 21172891|testing|C0039593^C0392366|start=556|end=563|CONC
 21172891|addition|C0332287^C1883712|start=568|end=576|CONC
 21172891|induction|C0857127^C0205263|start=586|end=595|PROC^CONC
 21172891|consolidation chemotherapy|C3179017|start=603|end=629|PROC
 21172891|methods|C0025664^C0449851^C0025663|start=674|end=681|CONC
 21172891|trial|C0008976|start=702|end=707|PROC
 21172891|age|C1114365^C0001779|start=752|end=755|PHYS
 21172891|years|C0439234|start=759|end=764|CONC
 21172891|assigned|C1552601^C1516050|start=780|end=788|CONC
 21172891|receive|C1514756|start=792|end=799|CONC
 21172891|single|C0205171|start=802|end=808|CONC
 21172891|dose|C0869039^C0178602|start=809|end=813|CONC
 21172891|day 1|C1442449|start=835|end=840|CONC
 21172891|induction|C0857127^C0205263|start=844|end=853|PROC^CONC
 21172891|course|C0750729|start=854|end=860|CONC
 21172891|following|C0332282|start=879|end=888|CONC
 21172891|induction|C0857127^C0205263|start=895|end=904|PROC^CONC
 21172891|schedules|C0086960^C1554217|start=905|end=914|CONC
 21172891|granulocyte|C0018183|start=1014|end=1025|ANAT
 21172891|colony|C1947989^C0439158|start=1026|end=1032|ANAT^CONC
 21172891|stimulating|C1948023|start=1033|end=1044|PHEN
 21172891|factor|C1521761^C2827422|start=1045|end=1051|CONC
 21172891|remission|C0687702|start=1072|end=1081|DISO
 21172891|assigned|C1552601^C1516050|start=1110|end=1118|CONC
 21172891|course|C0750729|start=1128|end=1134|CONC
 21172891|combination|C1947911^C0205195|start=1140|end=1151|OBJC^CONC
 21172891|primary|C0205225^C0439631|start=1223|end=1230|PROC^CONC
 21172891|response rate|C0237629|start=1247|end=1260|CONC
 21172891|survival|C0038952^C0220921|start=1265|end=1273|ACTI^CONC
 21172891|addition|C0332287^C1883712|start=1288|end=1296|CONC
 21172891|significant|C0750502^C1546944^C0237881|start=1330|end=1341|CONC
 21172891|increase|C0442805|start=1342|end=1350|CONC
 21172891|toxicity|C0600688^C0040539|start=1354|end=1362|DISO^CONC
 21172891|difference|C1705242^C1705241|start=1385|end=1395|CONC
 21172891|response|C2911692^C1706817^C0871261|start=1399|end=1407|PHYS^CONC
 21172891|survival|C0038952^C0220921|start=1411|end=1419|ACTI^CONC
 21172891|induction|C0857127^C0205263|start=1430|end=1439|PROC^CONC
 21172891|consolidation|C0702116|start=1443|end=1456|CONC
 21172891|analysis|C1524024^C0936012^C0002778|start=1480|end=1488|PROC^CONC
 21172891|cytogenetics|C0010802|start=1492|end=1504|OCCU
 21172891|highly significant|C1299395|start=1512|end=1530|CONC
 21172891|interaction|C1704675^C1546938^C0687133|start=1531|end=1542|PHYS^CONC
 21172891|induction|C0857127^C0205263|start=1548|end=1557|PROC^CONC
 21172891|significant|C0750502^C1546944^C0237881|start=1578|end=1589|CONC
 21172891|survival|C0038952^C0220921|start=1590|end=1598|ACTI^CONC
 21172891|benefit|C0814225|start=1599|end=1606|CONC
 21172891|favorable|C3640814|start=1625|end=1634|CONC
 21172891|cytogenetics|C0010802|start=1635|end=1647|OCCU
 21172891|benefit|C0814225|start=1652|end=1659|CONC
 21172891|poor|C1561558^C2700379^C1561559^C0542537^C0032854^C1547310|start=1678|end=1682|CONC
 21172891|risk|C0035647|start=1683|end=1687|CONC
 21172891|disease|C0012634|start=1688|end=1695|DISO
 21172891|trend|C1521798|start=1703|end=1708|CONC
 21172891|benefit|C0814225|start=1713|end=1720|CONC
 21172891|intermediate|C0205103^C1550465^C2827755|start=1724|end=1736|PHEN^CONC
 21172891|risk|C0035647|start=1737|end=1741|CONC
 21172891|internally|C0205102|start=1755|end=1765|CONC
 21172891|prognostic|C0220901|start=1776|end=1786|CONC
 21172891|index|C1552854^C0918012|start=1787|end=1792|CONC
 21172891|identified|C1551388^C0205396|start=1793|end=1803|CONC
 21172891|approximately|C0332232|start=1804|end=1817|CONC
 21172891|predicted|C0681842|start=1841|end=1850|CONC
 21172891|benefit|C0814225|start=1851|end=1858|CONC
 21172891|survival|C0038952^C0220921|start=1876|end=1884|ACTI^CONC
 21172891|conclusion|C1707478|start=1886|end=1896|CONC
 21172891|proportion|C1709707|start=1912|end=1922|CONC
 21172891|aml|C0023467|start=1948|end=1951|DISO
 21172891|improved|C0184511^C1561611^C0332272|start=1957|end=1965|CONC
 21172891|survival|C0038952^C0220921|start=1966|end=1974|ACTI^CONC
 21172891|addition|C0332287^C1883712|start=1984|end=1992|CONC
 21172891|induction chemotherapy|C3179010|start=2002|end=2024|PROC
 21172891|little|C0700321^C2700395|start=2030|end=2036|CONC
 21172891|additional|C1524062|start=2037|end=2047|CONC
 21172891|toxicity|C0600688^C0040539|start=2048|end=2056|DISO^CONC
